Paris BL[au] - Search Results

Year	Number of Results
2009	2
2010	1
2011	2
2012	1
2013	1
2019	1
2021	1
2022	0

1

Medication Safety in Two Intensive Care Units of a Community Teaching Hospital After Electronic Health Record Implementation: Sociotechnical and Human Factors Engineering Considerations.

Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Brown R, Hoonakker P, Kim R, Kukreja S, Johnson M, Paris BL, Wood KE, Walker JM. Carayon P, et al. Among authors: paris bl. J Patient Saf. 2021 Aug 1;17(5):e429-e439. doi: 10.1097/PTS.0000000000000358. J Patient Saf. 2021. PMID: 28248749

2

System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes.

Parkinson A, Kazmi F, Buckley DB, Yerino P, Ogilvie BW, Paris BL. Parkinson A, et al. Among authors: paris bl. Drug Metab Pharmacokinet. 2010;25(1):16-27. doi: 10.2133/dmpk.25.16. Drug Metab Pharmacokinet. 2010. PMID: 20208386 Free article. Review.

3

Diffusion, implementation, and use of Research Electronic Data Capture (REDCap) in the Veterans Health Administration (VA).

Paris BL, Hynes DM. Paris BL, et al. JAMIA Open. 2019 Jun 11;2(3):312-316. doi: 10.1093/jamiaopen/ooz017. eCollection 2019 Oct. JAMIA Open. 2019. PMID: 32537568 Free PMC article.

4

Conducting an efficient proactive risk assessment prior to CPOE implementation in an intensive care unit.

Hundt AS, Adams JA, Schmid JA, Musser LM, Walker JM, Wetterneck TB, Douglas SV, Paris BL, Carayon P. Hundt AS, et al. Among authors: paris bl. Int J Med Inform. 2013 Jan;82(1):25-38. doi: 10.1016/j.ijmedinf.2012.04.005. Epub 2012 May 16. Int J Med Inform. 2013. PMID: 22608242 Free PMC article.

5

An evaluation of the dilution method for identifying metabolism-dependent inhibitors of cytochrome P450 enzymes.

Parkinson A, Kazmi F, Buckley DB, Yerino P, Paris BL, Holsapple J, Toren P, Otradovec SM, Ogilvie BW. Parkinson A, et al. Among authors: paris bl. Drug Metab Dispos. 2011 Aug;39(8):1370-87. doi: 10.1124/dmd.111.038596. Epub 2011 Apr 27. Drug Metab Dispos. 2011. PMID: 21525169

6

In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.

Paris BL, Ogilvie BW, Scheinkoenig JA, Ndikum-Moffor F, Gibson R, Parkinson A. Paris BL, et al. Drug Metab Dispos. 2009 Oct;37(10):2045-54. doi: 10.1124/dmd.109.028274. Epub 2009 Jul 16. Drug Metab Dispos. 2009. PMID: 19608694

7

The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.

Ogilvie BW, Yerino P, Kazmi F, Buckley DB, Rostami-Hodjegan A, Paris BL, Toren P, Parkinson A. Ogilvie BW, et al. Among authors: paris bl. Drug Metab Dispos. 2011 Nov;39(11):2020-33. doi: 10.1124/dmd.111.041293. Epub 2011 Jul 27. Drug Metab Dispos. 2011. PMID: 21795468

8

An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.

Nassar AE, King I, Paris BL, Haupt L, Ndikum-Moffor F, Campbell R, Usuki E, Skibbe J, Brobst D, Ogilvie BW, Parkinson A. Nassar AE, et al. Among authors: paris bl. Drug Metab Dispos. 2009 Sep;37(9):1922-30. doi: 10.1124/dmd.109.027516. Epub 2009 Jun 11. Drug Metab Dispos. 2009. PMID: 19520774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results